respiratory syncytial virus, RSV, pediatric, vaccine
Showing 1 - 25 of >10,000
Respiratory Syncytial Virus (RSV) Trial in United States (Investigational RSV vaccine MV-012-968 (Dosage 1), Investigational RSV
Recruiting
- Respiratory Syncytial Virus (RSV)
- Investigational RSV vaccine MV-012-968 (Dosage 1)
- +5 more
-
Phoenix, Arizona
- +11 more
Aug 1, 2022
Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV/Flu-01E low dose
- +2 more
-
Saint Petersburg, Russian FederationSmorodintsev Research Institute of Influenza
Jul 24, 2023
Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus Trial in Rolling Hills Estates, Miami,
Recruiting
- Respiratory Syncytial Virus Infection
- +2 more
- RSV/hMPV vaccine candidate Dose L
- +3 more
-
Rolling Hills Estates, California
- +2 more
Nov 14, 2023
Respiratory Syncytial Virus Infections Trial in Baltimore, Laurel (RSV ?NS2 ?1313 I1314L Vaccine, Placebo)
Recruiting
- Respiratory Syncytial Virus Infections
- RSV ΔNS2 Δ1313 I1314L Vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Dec 2, 2022
Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe
Not yet recruiting
- Respiratory Syncytial Viruses
- Prior standard of care receipt of Pfizer's ABRYSVO vaccine
- (no location specified)
Oct 5, 2023
Respiratory Syncytial Virus Trial in Panama, United States (mRNA-1345, Placebo)
Not yet recruiting
- Respiratory Syncytial Virus
- mRNA-1345
- Placebo
-
Banning, California
- +20 more
Oct 18, 2023
Respiratory Syncytial Virus Infections Trial in Cincinnati (PIV5-vectored RSV Vaccine (BLB-201) Low Dose, PIV5-vectored RSV
Not yet recruiting
- Respiratory Syncytial Virus Infections
- PIV5-vectored RSV Vaccine (BLB-201) Low Dose
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 20, 2022
RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (RSVpreF 120 µg, RSVpreF 60 µg, )
Not yet recruiting
- RESPIRATORY SYNCYTIAL VIRUS (RSV)
- RSVpreF 120 µg
- +2 more
- (no location specified)
Jun 2, 2023
Respiratory Syncytial Virus Infections Trial (Placebo, Active)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- Placebo
- Active
- (no location specified)
Oct 20, 2023
RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (Substudy A (Study Intervention), Substudy A (Placebo), Substudy B)
Not yet recruiting
- RESPIRATORY SYNCYTIAL VIRUS (RSV)
- Substudy A (Study Intervention)
- +2 more
- (no location specified)
Apr 24, 2023
Respiratory Syncytial Virus Infections Trial (CodaVax-RSV, Normal Saline)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- CodaVax-RSV
- Normal Saline
- (no location specified)
Nov 16, 2022
Burden of Respiratory Syncytial Virus in Sweden: A Retrospective
Active, not recruiting
- Respiratory Syncytial Virus (RSV)
- (no location specified)
Nov 10, 2022
Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)
Not yet recruiting
- Respiratory Syncytial Virus Infection
- Sisunatovir
- Placebo
- (no location specified)
Oct 6, 2023
Respiratory Syncytial Virus Infection Trial in Carolina, Guayama, San Juan (RSVt Vaccine, Control Group)
Recruiting
- Respiratory Syncytial Virus Infection
- RSVt Vaccine
- Control Group
-
Carolina, Puerto Rico
- +2 more
Feb 2, 2023
Respiratory Syncytial Virus Trial in London (Molnupiravir, Placebo, RSV A Memphis 37b)
Recruiting
- Respiratory Syncytial Virus
- Molnupiravir
- +2 more
-
London, London, City Of, United KingdomhVIVO Services ( Site 0001)
Feb 2, 2023
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- PCV20
- (no location specified)
May 18, 2023
Respiratory Syncytial Virus (RSV) Trial in Rochester (RSV vaccine)
Not yet recruiting
- Respiratory Syncytial Virus (RSV)
- RSV vaccine
-
Rochester, New YorkUniversity of Rochester Medical Center
Oct 11, 2023
COVID-19 Respiratory Infection, Influenza A, Influenza Type B Trial in Pasadena (Labcorp COVID-19+Flu+RSV Test Home Collection
Recruiting
- COVID-19 Respiratory Infection
- +3 more
- Labcorp COVID-19+Flu+RSV Test Home Collection Kit
-
Pasadena, CaliforniaExer Urgent Care
Aug 21, 2023
Respiratory Syncytial Virus Infections Trial (RSVPreF3 vaccine, Control)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 vaccine
- Control
- (no location specified)
Jan 20, 2023
Respiratory Syncytial Virus Infections Trial in Fukuoka (RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B
- Placebo
-
Fukuoka, JapanGSK Investigational Site
Dec 7, 2021
Respiratory Syncytial Virus Infections Trial in United States (RSV LID cp ?M2-2 Vaccine, Placebo)
Terminated
- Respiratory Syncytial Virus Infections
- RSV LID cp ΔM2-2 Vaccine
- Placebo
-
Los Angeles, California
- +4 more
Nov 4, 2021
RESCEU: Defining the Burden of RSV Disease
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV Infection
- venepuncture
- nasopharyngeal swab
-
Oxford, Oxfordshire, United KingdomUniversity of Oxford
Oct 25, 2022
RSV Infection Trial in London (MVA-mBN294B, Placebo)
Completed
- RSV Infection
- MVA-mBN294B
- Placebo
-
London, United KingdomhVIVO Services Limited
Mar 31, 2022
Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV) Trial in Ha Noi (0.9% NaCl physiological
Recruiting
- Acute Respiratory Tract Infections
- +2 more
- 0.9% NaCl physiological saline
- LiveSpo Navax
-
Ha Noi, VietnamThe Center for Pulmonology and Respiratory Care, Vietnam Nationa
Jul 4, 2023